Meeting
2016 ASCO Annual Meeting
Disparities in treatment patterns and outcomes between caucasian and African American patients with multiple myeloma (MM).
Authors
Safiya Abouzaid
Celgene Corporation, Summit, NJ
Safiya Abouzaid , Kejal Parikh , Zheng-Yi Zhou , Zhou Zhou , Wenxi Tang , Jipan Xie , Manali I. Patel
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Hematologic Malignancies—Plasma Cell Dyscrasia
Track
Hematologic Malignancies—Plasma Cell Dyscrasia
Sub Track
Multiple Myeloma
Citation
J Clin Oncol 34, 2016 (suppl; abstr 8022)
DOI
10.1200/JCO.2016.34.15_suppl.8022
Abstract #
8022
Poster Bd #
287
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Lack of racial disparity in outcome of African American (AA) and Caucasian patients with symptomatic multiple myeloma (MM) at the Veterans Affairs (VA) hospitals.
First Author: Nathanael Fillmore
Poster
2015 ASCO Annual Meeting
Real-world treatment patterns, healthcare resource utilization (HRU), and costs of initial line of therapy (LOT1) in multiple myeloma (MM).
First Author: Stacey DaCosta Byfield
Poster
2013 ASCO Annual Meeting
Efficacy and cost of peripheral blood stem cell (PBSC) mobilization with low-dose cyclophosphamide (LD-CY) compared with plerixafor (P) in multiple myeloma (MM) patients (pts) treated with novel induction therapies.
First Author: Lubna Chaudhary
Poster
2012 ASCO Annual Meeting
Impact of t (11;14) on the outcome of autologous hematopoietic cell transplantation (Auto-HCT) in multiple myeloma.
First Author: Koji Sasaki